http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113150076-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 |
filingDate | 2021-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-113150076-B |
titleOfInvention | Synthesis method of cyclic pentapeptide and application of cyclic pentapeptide in anti-hepatitis C drugs |
abstract | The invention provides a cyclic pentapeptide, the amino acid sequence of which is as follows: cyclo-5-aspartic acid-glutamic acid-arginine-tyrosine-arginine. The cyclic pentapeptide inhibitor provided by the invention has good structural stability, can be efficiently combined with p7 channel protein, and effectively exerts the effect of resisting hepatitis C virus. |
priorityDate | 2021-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 185.